Marti Technologies, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MRT research report →
Range $2.2 – $4
Price Chart
About the company
Marti Technologies Inc. (MRT), headquartered in Istanbul, Turkey, specializes in urban mobility. The company provides city-dwellers across Turkey with a range of transportation solutions via its proprietary mobile application.
- CEO
- Oguz Alper Oktem
- IPO
- 2021
- Employees
- 473
- HQ
- Istanbul, IB, TR
Get TickerSpark's AI analysis on MRT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $166.92M
- P/E
- -3.91
- Fwd P/E
- 26.45
- PEG
- -0.05
- P/S
- 2.77
- P/B
- -1.99
- EV/EBITDA
- -36.66
- Div Yield
- 0.00%
- Gross Margin
- 70.79%
- Op Margin
- -17.56%
- Net Margin
- -69.78%
- ROE
- 58.01%
- ROIC
- -45.00%
Latest fiscal year · YoY change
- Revenue
- $39.24M+110.3%
- Gross Profit
- $3.64M+107.7%
- Op Income
- $-20,024,185
- Net Income
- $-41,446,038+43.9%
- EPS
- $-0.53+57.6%
- OCF Growth
- +41.1%
- FCF Growth
- +41.5%
- 52W High
- $2.75
- 52W Low
- $1.12
- 50D MA
- $1.98
- 200D MA
- $1.98
- Beta
- 0.36
- RSI (14)
- 46
- Avg Volume
- 55.08K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Marti said Q2 2026 was an inflection point, with revenue up 141% year over year, gross margin at a record 77%, and adjusted EBITDA positive for the first time.· August 19, 2026
- Revenue rose 141% year over year to nearly $20 million, while gross profit more than tripled to over $15 million.
- Adjusted EBITDA turned positive at $2.9 million, an improvement of $5.3 million from the prior-year quarter.
- Trips increased 73% to 18.8 million and unique platform consumers grew 76% to 2.4 million, with engagement remaining broadly stable.
- Management lifted full-year 2026 guidance to $85 million of revenue and positive $7 million adjusted EBITDA.
- The business expanded to 30 cities, and management said growth is now coming more from outside Istanbul, where the company expects monetization to remain phased.
Marti reported Q2 2026 revenue of nearly $20 million, up 141% year over year; gross profit of over $15 million, up 223%; gross margin of 77% versus 57% a year ago; and adjusted EBITDA of $2.9 million versus negative $2.4 million in Q2 2025. On a GAAP basis, net loss was $12.5 million, including an $8.3 million noncash loss on debt extinguishment; excluding that item, net loss was $4.2 million versus $9.2 million last year. Trips rose 73% to 18.8 million and unique platform consumers rose 76% to 2.4 million. For full-year 2026, management raised guidance to $85 million in revenue and positive $7 million in adjusted EBITDA.
Oguz Oktem framed the quarter as a proof point that scale is translating into profitability, calling it an “inflection point” and highlighting the company’s marketplace strategy of building the largest mobility network in Türkiye and expanding into adjacent services. He emphasized ride-hailing as the core growth engine, delivery adoption as an added lever, and autonomous mobility as a longer-term opportunity through the newly announced Türkiye Autonomous Vehicle Alliance and Tensor partnership. His tone was upbeat and expansion-focused, repeatedly stressing nationwide reach, higher engagement, and AI-enabled operating efficiency.
Cankut Durgun focused on the operating leverage behind the quarter: revenue up 141%, cost of revenues up only 32%, cost of revenues down to 23% of revenue from 43%, and gross margin expanding to 77%. He noted personnel expenses fell from 16.5% to 7.6% of revenue, D&A from 8.5% to 2.6%, and operating lease expenses from 4.2% to 1.3%. He also pointed to a 4.4 million all-time riders base, 544,000 registered drivers, a reduction in average daily e-vehicles deployed from 24,100 to 20,900, and reiterated the $85 million revenue / $7 million adjusted EBITDA outlook. On capital allocation, he said the company has up to a $2.5 million buyback program and will continue repurchasing shares if they remain undervalued, while still prioritizing growth investments like city launches and rider/driver acquisition.
Analysts pressed management on whether 78% gross margin was a ceiling, and Cankut replied that while margins do have a ceiling because the business has offline operational costs, something in the 80% range appears sustainable for now. Questions also focused on why guidance was raised and what drove growth: management said the revenue upgrade was mainly due to faster-than-expected trip volume, not new-city monetization assumptions, and that EBITDA guidance was supported by strong gross profit and current quarterly run-rate. On geography, Cankut said growth is coming primarily outside Istanbul, with Istanbul now below 50% of the business and steady-state expectations closer to one-third. On autonomous vehicles, management said deployment depends first on proving safety and regulatory readiness in Türkiye, with pilots likely before any larger financing commitments; on delivery, they said parcel delivery is still in Phase 1 and currently Istanbul-based, with expansion to other cities planned later.
The call showed strong momentum in Marti’s core marketplace, with rapid rider and trip growth, stable engagement, and sharply better unit economics. Management also sounded confident that the business can sustain around 80% gross margins and still fund growth, while new-city expansion, delivery adoption, AI tooling, and the Tensor/AV partnership provide additional long-term options.
Management acknowledged gross margins have a ceiling because the business has real-world operating costs, and they said competition could affect margins if it intensifies. They also said new cities will not be monetized until 2027 at the earliest, parcel delivery remains early and Istanbul-centric, and autonomous vehicle deployment depends on proving safety and getting the regulatory framework right before any meaningful scale or capital commitment.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 33.9%
- Shares Outstanding
- 86.04M
- Float Shares
- 29.15M
of shares held by institutions
15 13F filers
Buy/sell ratio 5.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for MRT, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Greg GianforteHouse · MT00 | Buy | Dec 21, 18 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Dld Asset Management, LP | 7.06M | ▲ 497.00K |
| Gramercy Funds Management LLC | 2.57M | ▲ 242.38K |
| Wells Fargo & Company/Mn | 1.00M | 0 |
| Luxor Capital Group, LP | 355.99K | 0 |
| Arbiter Partners Capital Management LLC | 323.08K | ▲ 36.82K |
| Weiss Asset Management LP | 308.90K | ▲ 181.50K |
| Advisor Group Holdings, Inc. | 158.79K | ▲ 158.79K |
| Rmb Capital Management, LLC | 35.00K | 0 |
| Cjm Wealth Advisers, Ltd. | 35.00K | 0 |
| Bbr Partners, LLC | 35.00K | 0 |
| State Street Corp | 31.33K | ▼ 2.30K |
| Xtx Topco Ltd | 10.24K | ▲ 10.24K |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 18, 26 | Freifeld Daniel | sell | 500,000 |
| Jun 15, 26 | Freifeld Daniel | sell | 500,000 |
| Sep 9, 26 | Freifeld Daniel | sell | 350,000 |
| Sep 30, 26 | Freifeld Daniel | other | 20,261 |
| Sep 30, 26 | Healey Kerry Murphy | other | 3,732 |
| Sep 30, 26 | Lute Douglas | other | 3,732 |
| Sep 30, 26 | Spiro Alex | other | 2,666 |
| Sep 30, 26 | Ugur Agah | other | 3,199 |
| Jun 30, 26 | Healey Kerry Murphy | other | 3,732 |
| Jun 30, 26 | Lute Douglas | other | 3,732 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our MRT coverage
Recent articles, reports, and earnings notes.
No research on MRT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MRT report →Monte Rosa's MRT-8102 Shows Biomarker Gains in GFORCE-1 Study
marketbeat.com · Oct 6
Monte Rosa Therapeutics Announces Positive Results for MRT-8102 in GFORCE-1 Phase 1 Study Showing Normalization of Key Pathogenic Drivers of ASCVD in Subjects with Elevated CVD Risk
globenewswire.com · Oct 1
Monte Rosa Therapeutics to Present Results of MRT-8102 GFORCE-1 Phase 1 Study in Subjects with Elevated Cardiovascular Disease Risk
globenewswire.com · Sep 30
Marti Increases Share Repurchase Authorization to $5 Million and Extends Program Through April 2027
businesswire.com · Sep 10
Monte Rosa Therapeutics Announces Milestone Achievement Associated with Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)
globenewswire.com · Sep 8
Marti's Ride-Hailing Service Reaches 4.90 Million Riders and 584 Thousand Registered Drivers, Exceeding September 30, 2026 Targets a Month Earlier Than Planned
businesswire.com · Sep 3
Marti Technologies: Buy The Inflection Point
seekingalpha.com · Aug 24
Monte Rosa Therapeutics Announces First Patient Dosed in MODeFIRe-1, a Phase 2 Study of MRT-2359 in Combination with Apalutamide in Patients with AR Mutation-Positive Metastatic Castration-Resistant Prostate Cancer
globenewswire.com · Aug 24
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.